JPY 1090.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 67.72 Million JPY | 267.09% |
2022 | 18.44 Million JPY | 128.78% |
2021 | 8.06 Million JPY | 167.11% |
2020 | 3.01 Million JPY | -66.46% |
2019 | 9 Million JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 63 Million JPY | -6.98% |
2023 Q4 | 67.72 Million JPY | -7.15% |
2023 Q3 | 72.94 Million JPY | 66.33% |
2023 Q2 | 43.85 Million JPY | 31.2% |
2023 Q1 | 33.42 Million JPY | 81.18% |
2023 FY | 67.72 Million JPY | 267.09% |
2022 Q3 | 22.23 Million JPY | 1.04% |
2022 Q2 | 22 Million JPY | 0.0% |
2022 Q4 | 18.44 Million JPY | -17.03% |
Name | Inventory | Inventory Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 12.37 Billion JPY | 99.453% |
Cosmo Bio Company,Limited | 1.03 Billion JPY | 93.475% |
H.U. Group Holdings, Inc. | 22.46 Billion JPY | 99.698% |
FALCO HOLDINGS Co., Ltd. | 1.46 Billion JPY | 95.38% |
BML, Inc. | 4.58 Billion JPY | 98.523% |
Human Metabolome Technologies, Inc. | 36.99 Million JPY | -83.09% |
Precision System Science Co., Ltd. | 1.69 Billion JPY | 96.004% |